Literature DB >> 18230356

Clinical relevance of measurement of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in pediatric cardiology.

Massimiliano Cantinotti1, Aldo Clerico, Michele Murzi, Simona Vittorini, Michele Emdin.   

Abstract

BACKGROUND: The aim of this review is to understand the clinical usefulness of Brain Natriuretic Peptide (BNP) and N-terminal pro-Brain Natriuretic Peptide (NT-proBNP) in pediatric cardiology.
METHODS: A computerized literature search on National Library of Medicine using the keywords "BNP assay" and "NT-proBNP assay" was performed. Then, we refined the analysis to include only the studies specifically designed to evaluate the clinical usefulness of BNP and NT-proBNP assays in patients with congenital heart disease.
RESULTS: BNP and NT-proBNP are useful marker for diagnosis of heart failure, for the assessment of clinical severity and for the follow-up of congenital and pediatric heart diseases. However, results from different studies are often partial and not always univocal. Moreover, reference intervals in pediatric population have not yet been extensively evaluated.
CONCLUSIONS: BNP and NT-proBNP may be considered helpful markers for the integrated diagnosis and management of pediatric patients, though further studies are needed to support their routine use.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18230356     DOI: 10.1016/j.cca.2007.12.020

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  4 in total

1.  B-type natriuretic Peptide assay for the diagnosis and prognosis of patent ductus arteriosus in preterm infants.

Authors:  Joon Sik Kim; Eun Jung Shim
Journal:  Korean Circ J       Date:  2012-03-26       Impact factor: 3.243

2.  B-type natriuretic peptide and heart failure in patients with ventricular septal defect: a pilot study.

Authors:  Michael A Paul; Carl L Backer; Helen J Binns; Constantine Mavroudis; Catherine L Webb; Ram Yogev; Wayne H Franklin
Journal:  Pediatr Cardiol       Date:  2009-07-28       Impact factor: 1.655

Review 3.  The potential and limitations of plasma BNP measurement in the diagnosis, prognosis, and management of children with heart failure due to congenital cardiac disease: an update.

Authors:  Massimiliano Cantinotti; Yuk Law; Simona Vittorini; Maura Crocetti; Marotta Marco; Bruno Murzi; Aldo Clerico
Journal:  Heart Fail Rev       Date:  2014-11       Impact factor: 4.214

4.  NT-proBNP in Children With Left to Right Shunt and Dilated Cardiomyopathy.

Authors:  Hala Mahmoud Koura; Neamat M Abdalla; Mona Hamed Ibrahim; Maha M A Abo Hashish; Sherif Mohamed Zaki
Journal:  Iran J Pediatr       Date:  2016-05-15       Impact factor: 0.364

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.